-
1 Comment
From a valuation standpoint, the stock is 5.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.0.
Based on the above factors, Biolidics Limited gets an overall score of 1/5.
| ISIN | None |
|---|---|
| Exchange | SG |
| CurrencyCode | SGD |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| PE Ratio | None |
|---|---|
| Market Cap | 34M |
| Beta | 0.43 |
| Target Price | None |
| Dividend Yield | None |
Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also provides laboratory services. The company was incorporated in 2009 and is based in Singapore.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8YY.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
